Skip to main content

Green analytical chemistry and experimental design: a combined approach for the analysis of zonisamide


Green analytical chemistry principles, as well as experimental design, are a combined approach adopted to develop sensitive reproducible stability indicating HPLC method for Zonisamide (ZNS) determination. The optimal conditions for three chromatographic parameters were determined using a central composite design of the response surface. Kromasil C18 column (150 mm × 4.6 mm, 5 µm) was utilized with ethanol, H2O (30:70 v/v) as a mobile phase at a flow rate of 1 mL/min at 35 °C. Good reproducibility and high sensitivity were achieved along (0.5–10 µg/mL) concentration range. In contrast, the TLC-densitometric method was performed on aluminum plates precoated with silica gel 60F254 as a stationary phase and chloroform: methanol: acetic acid (8:1.5:0.5 by volume) as a developing system. Reproducible results were obtained in the range of (2–10 μg/band). The chromatograms of HPLC and TLC were scanned at 280 nm and 240 nm, respectively. The suggested methods have been validated following ICH guidelines, and no statistically significant differences were detected between the results of the current study and the official USP method. It was also found that using experimental design implements the green concept by reducing the environmental impact. Finally, Eco-Scale, GAPI and AGREE were used to assess the environmental impacts of the suggested methods.

Peer Review reports


Green chemistry was implemented by Paul Anastas, which was designated to substitute hazardous solvents with less or non-toxic ones [1]. Substituting methanol or acetonitrile with ethanol or water as green solvents were adopted in pharmaceutical analysis, particularly in chromatographic techniques [2]. Furthermore, eco-friendly mobile phases meet the requirements of the US Environmental Protection Agency for reducing the hazardous environmental effects of analysis wastes [3].

In compliance with green analytical chemistry principles recently, application of experimental design in developing and optimizing chromatographic methods has taken a significant concern. The ability of experimental design to simultaneously analyze multiple variables and their effects qualifies it as economical and environmentally friendly approach, as it reduces the experiments and hence consumption of solvents in accordance with achieving separation of drugs in combination or the presence of its degradation products as well as impurities [4,5,6,7,8,9].

Zonisamide is a USP-approved medication with IUPAC name 1, 2-benzoxazol-3-yl methanesulfonamide (Fig. 1) [10], which is a member of the methanesulfonamide family with anticonvulsant properties. ZNS suppresses tonic–clonic as well as partial seizures in humans, in addition to preserving neurons from the damage induced by free radicals [11, 12].

Fig. 1
figure 1

Chemical structure of Zonisamide

By reviewing the literature, different methods were reported for determining ZNS either in pharmaceutical dosage form or biological fluids utilizing HPLC [13,14,15,16,17,18], capillary electrophoresis [19, 20], HPTLC [21, 22], and electroreduction at hanging mercury drop electrode [23]. To date, only a few stability-indicating methods were published for ZNS determination in the presence of its degradation products using HPLC [24,25,26,27,28] and spectrophotometric techniques [26, 29].

In this manuscript, the ZNS degradation pathway was demonstrated, and the degradation product was isolated, besides elucidating its structure utilizing IR and mass spectroscopy.

This study aims to develop and optimize simple, precise, and robust stability-indicating chromatographic methods that can be easily applied in the routine quantitative ZNS analysis. In addition to, HPLC method assisted with the Central Composite Design of the response surfaces to optimize the method so the number of experiments is minimized to achieving ecofriendly, time and cost-saving method.

TLC densitometry excels other methods as it enables rapid analysis as various samples can be tracked all together in the same time. Uses simple procedure and it is cost effective where small amount of solvent are consumed. The mentioned characteristics of both suggested methods are in line with the global trend toward application of ecofriendly techniques.


Apparatus and software

The thin-layer chromatography (TLC) system consists of 100 μL Camag micro syringe (Muttenz, Switzerland) as well as Camag Linomat autosampler (Camag, Switzerland). TLC was performed utilizing 0.25 mm thickness TLC plates pre-coated with silica gel G.F254 20X20 cm (Merck, Darmstadt, Germany), winCATS software, and a short wavelength (254 nm) ultraviolet (UV) lamp (USA).

The HPLC system consists of Waters Alliance 2695 Separations Module using inline vacuum degassing with different flow rates, an autosampler, and programmable temperature control. A heated column compartment provides temperatures from 5 degrees above ambient to 65 °C. The wavelength range of model 2996 photodiode array detector is 190–800 nm. Stationary phase was Kromasil® MS C18 column (150 mm × 4.6 mm, 5 µm) (Nouryon, Bohus, Sweden).Whatman syringe filter (Fisher, Nederland) was utilized. For IR and mass spectrometric analysis, an infrared (IR) spectrometer (Shimadzu, Japan) and an Ultra-performance liquid chromatography-mass spectrometer (LC/MS/MS) (Waters, Milford, USA) were used. Design-Expert software was used for data analysis (version 12) (Godward St NE, Minneapolis). Hot plate and pH meter were used (Jenway, Stone, UK).

Chemicals and reagents

  • Methanol and ethanol HPLC grade (Sigma Aldrich, MO, USA).

All other chemicals utilized in this work were of analytical grade.

  • Analytical grade Chloroform (Merck, Germany).

  • Acetic acid and Hydrogen peroxide (Al—Gomhoria Company, AZ Zaytoun Al Qebleyah, Cairo, Egypt).

  • In-house preparation of double-distilled water was performed utilizing the AQUATRON water still A8000 system (Stone, Staffordshire, UK).

  • Zonisamide was obtained from Mash premiere pharmaceuticals (Cairo, Badr city, Egypt), its purity was 99.87 ± 0.81 as per the USP official method [10].

  • Convagran® Hard gelatin Capsules, Batch No. M2012417 labeled to contain 25 mg/Capsule, Batch No. M2013617 labeled to contain 50 mg/Capsule, and Batch No. M2000918, labeled to contain 100 mg/Capsule, manufactured by Mash premiere Pharmaceutical (Badr City, Egypt), were bought from a local market.

  • The degradation product was performed as detailed in the procedures.

Standard solutions

  • Zonisamide stock standard solution (1 mg/mL) prepared in methanol.

  • The degradation product's stock standard solution (Equivalent to 1 mg/mL ZNS), as illustrated in the procedures section, was prepared and quantitatively transferred into a volumetric flask of (25 mL), and then the volume was reached to the mark with methanol.

  • Working solutions for the HPLC method

In order to obtain 100 µg/mL of working standard solutions in methanol, 10 mL of standard ZNS stock solutions, as well as the degradation product, were separately transferred into two volumetric flasks (100 mL/each).


Zonisamide degradation product preparation

From ZNS pure powder, 25 mg were weighed and transferred into 25 mL volumetric flask. The minimum amount of methanol was then added for dissolving ZNS. The volume was reached the mark with 10% H2O2 and the solution was refluxed on a hot plate at 80 °C for 16 h. TLC aluminum sheets were utilized to assure complete sample degradation every two hours, using chloroform: methanol: acetic acid (8:1.5:0.5 by volume) as a developing system. The fully degraded solution was subsequently evaporated to dryness, cleansed by dissolving in methanol and re-evaporated multiple times. Finally, IR and mass spectroscopy were utilized to elucidate degradation product structure.

Calibration curve of TLC-Densitometry method

Application of various aliquots from the ZNS stock solution was performed on the TLC plates and developed up to 8.5 cm using developing system [chloroform: methanol: acetic acid (8:1.5:0.5 by volume)]. The plates were air-dried, and the spots were visualized at 254 nm under a UV lamp. Chromatograms were scanned at 240 nm. The polynomial equation was derived from a calibration curve depicting the correlation between integrated peak area and the corresponding ZNS concentrations in range of (2-10 µg/band).

Calibration curve of HPLC method

Five to one hundred micrograms of the working ZNS standard solution (100 µg/mL) were transferred separately into a set of volumetric flasks (10 mL/each); the volume was completed until reaching the mark with the mobile phase, and each concentration was repeated in triplicate. Samples were filtered utilizing syringe filters, and the separation was performed on Kromasil® C18 column (150 mm, 4.6 mm, i.d.5 μm) using ethanol: H2O (30:70 v/v) as mobile phase with 10 µL injection volume, at flow rate of (1 mL/min) and temperature was adjusted to be 35 °C. At 280 nm, chromatograms were observed. After constructing the calibration curve via plotting the peak area against the corresponding concentrations of ZNS, the linear regression equation was determined.

Application to pharmaceutical formulations

Ten hard gelatin capsules of Convagran® from each of the three dosage forms were emptied, and each powder was thoroughly mixed. A stock solution for each dosage form claimed to contain (1 mg/mL) ZNS was prepared by weighing the accurate amount from each powder into three suitable separate volumetric flasks. The powder was dissolved with methanol, sonicated for 20 min, and then filtered.

For the TLC method: Different aliquots from each dosage form stock capsule solutions were spotted on the TLC plates.

For HPLC method: The working solution for each dosage form was prepared by diluting 10 mL of stock solutions into three separate volumetric flasks (100 mL/each). Aliquots were transferred from working solutions into three separate series of volumetric flasks (10 mL/each), and the volume was brought up to the mark with the mobile phase.

Results and discussion

Solvents in the pharmaceutical field are more than half of the material used in the manufacturing process or the analysis of their finished products. Several environmental organizations and agencies worldwide strive to conserve the environment against human misuses, such as Environmental Protection Agency and Global Environment Facility. One of their solutions to attain their goals of reducing economic and environmental losses; is to use green solvents. Therefore, the present study aimed to use green solvents while determining zonisamide in the presence of its degradation product.

Zonisamide degradation

Submission of the accelerated stability studies [6 months] and late stability studies [3 years] for Governmental agencies regulating medication are mandatory in the registration of a new drug for manufacture. In the pharmaceutical industry, stability studies are considered in order to ensure that no changes will occur in the concentration of the active ingredients and that no toxic degradation products will be formed, as well as to determine the optimal storage conditions [30, 31]. ZNS breakdown when refluxed with 10% H2O2 for 16 h at 80 °C of continuous heating. Spot of different Rf values was observed for the oxidative degradation product and confirmed by examining the solution every two hours on TLC plates using chloroform: methanol: acetic acid (8:1.5:0.5 by volume) as a developing system which proved complete degradation. It is worth mentioning that ZNS showed stability towards different concentrations of HCl and NaOH (0.1N, 1N, 2N, and 5N) at varying temperatures.

Infrared (IR) and mass spectroscopy, were utilized for elucidating the degradation product structure. IR spectrum of pure ZNS (Fig. 2A) indicates the existence of a characteristic band at 1338 cm−1 corresponding to the sulfonamide group, which is still apparent in the degradation product IR spectrum. Furthermore, the existence of a band at 1712 cm−1 indicates the presence C = O and a broad band at 3000 to 3500 cm−1 indicates the existence of alcoholic OH group in the degradation product's IR spectrum (Fig. 2B).

Fig. 2
figure 2

A IR spectra of intact ZNS and B IR spectra of degradation product

The negative ESI–MS scan demonstrated a ZNS molecular ion peak at (m/z = 210.88) (Fig. 3A) while (m/z = 177) for the ZNS degradation product of the positive ESI–MS scan (Fig. 3B). Accordingly, the oxidative degradation pathway ZNS was expected, as shown in (Fig. 4).

Fig. 3
figure 3

A Negative ESI–MS of zonisamide, B Positive ESI–MS of zonisamide oxidative degradation product

Fig. 4
figure 4

Suggested pathway for oxidative degradation of zonisamide

TLC Method

Zonisamide was estimated in the presence of its degradation product using the densitometric method after a number of preliminary trials. These trials were performed utilizing various developing systems in varying ratios until determining the optimal conditions with promising results. A tailed degradation product's peak was observed using the following developing systems [ethyl acetate: acetic acid] and [butanol: propanol]. A poor resolution was obtained upon using [methanol: butanol: chloroform] and [propanol: butanol: chloroform]. Different ratios of [chloroform: methanol: acetic acid] have been experimented as developing system. Multiple attempts to reduce chloroform and methanol volume were investigated in order to minimize their harmful impact. No separation was observed when the volume of chloroform is lower than 8 mL. The results were satisfactory upon using ratio of (8:1.5:0.5 by volume) where the degradation product spot is no longer retained at the baseline. At 240 nm, the densitogram was scanned, and Rf values were 0.76 for ZNS and 0.11 for its degradation product (Fig. 5). There is a polynomial correlation between the integrated peak area and the corresponding ZNS concentration ranging between (2 to 10 µg/band) at 240 nm, which was the wavelength of choice where both ZNS and its degradation demonstrate good sensitivity.

Fig. 5
figure 5

TLC densitogram of Zonisamide (Rf = 0.76) and its degradation product (Rf = 0.11) at 240 nm

HPLC Method

In our work, preliminary trials were conducted to determine the optimal column type, length, and temperature, as well as the optimal ratio of the green mobile phase. Cyano and C18 columns were initially evaluated in order to select the one that progressively improve the system suitability parameters. Cyano column showed poor resolution with tailing peak for both analytes; in contrast to C18. Different temperatures) 25, 30, and 35 °C( were tried and no significant effect was observed on retention time, but the bifid peak shape was overcome at temperature ˃ (25 °C). Different ratios of [ethanol: H2O] were tried and it has been noticed that upon increasing water percentage, the retention time increased.

Regular practice during developing HPLC methods usually relies on studying each variable and its effect separately, which is time and cost-consuming [32, 33]. This paper refers to the application of a central composite of surface response design of expert that has the advantages of studying various variables simultaneously, in addition to optimization of HPLC conditions. Accordingly, the time and cost consumption will be decreased [34,35,36,37,38,39].

This work applied experimental design to investigate three factors and analyze their effect simultaneously. Mobile phase ratio, flow rate, and temperature were three factors significantly affect the HPLC response. The experimental design is based on two factorial levels coded with [−1] for each factor's low level and [+ 1] for the high level. According to preliminary studies results, the ratio of the mobile phase in the low level was 70% and in the high level was 90%; however, the flow rate was [1 mL/min] for low and [1.5 mL/min] for high. Finally, the temperature factor is 25 °C for low level and 35 °C for high level. The design of expert software suggested a total of twenty runs, including six center point runs, to examine the effect of each factor on resolution, retention time, and tailing factor. The objective of the statistical analysis using Derringer's desirability function was to achieve maximum resolution with the shortest retention time. Maximum resolution value was attained at a higher percentage of water (90%) and 1 mL/min flow rate (Fig. 6A). However, the lowest retention time was achieved at the percentage of water in mobile phase (~ 60%) and 1.25 mL/min flow rate (Fig. 6B). There was no significant effect observed on tailing value, as demonstrated in (Fig. 7).

Fig. 6
figure 6

Contour surface diagrams showing the effects of water % and flow rate on A Resolution (Rs) and B Retention time (Rt)

Fig. 7
figure 7

The 3D surface response plot of desirability for optimization of factors A Resolution (Rs), B Retention time (Rt) and C Tailing (T)

As suggested by the experimental design, the optimal ZNS chromatographic separation from its degradation product was achieved utilizing Kromasil® MS C18 (150 mm, 4.6 mm, i.d.5 μm) column at 35 °C with green as well as eco-friendly mobile phase containing [ethanol: H2O (30:70 v/v)], at (1 mL/min). Linear correlation between the peak area the corresponding ZNS concentration ranging between 2 to 10 µg/mL was scanned at 280 nm (Fig. 8), and the regression equation was determined as A = 14327C − 300.15 r = 1, where A represents the peak area, r is the correlation coefficient, and C is the concentration in μg/mL.

Fig. 8
figure 8

HPLC chromatogram of ZNS of 50 µg/ml (tR = 2.806) and its degradate of 10 µg/ml (tR = 1.553) at 280 nm

The results of system suitability parameters revealed that the proposed system is adequate for analyzing ZNS and the parameters calculated per the USP guidelines (Table 1) [10]. In addition, satisfactory results for validation parameters were presented for both suggested methods in (Table 2) according to ICH guidelines (Q2) R1 recommendations [40]. The proposed methods were effectively guaranteed for the analysis of ZNS in Convagran® capsules, and the methods was further validated via the application of the standard addition technique (Table 3). Additionally, a statistical comparison of the results obtained from the pharmacopeia HPLC method [10] and the proposed methods showed no significant differences regarding precision, and accuracy (Table 4).

Table 1 Parameters required for system suitability tests of TLC–densitometric and HPLC methods
Table 2 Assay and validation parameters for the determination of ZNS by the proposed methods
Table 3 Determination of ZNS in its pharmaceutical form and application of standard addition technique results using the proposed methods
Table 4 Statistical comparison between the results obtained by the proposed methods and the pharmacopeial method for the analysis of ZNS

To the best of our knowledge, the proposed TLC method is the first for determining ZNS along with its degradation product. The HPLC proposed method has an advantage over other published methods [41, 42], as it is the first methodology to determine ZNS in the presence of its degradation product using green analysis coupled with an Experimental Design, which in turn decreases the number of trials performed hence making it the most economical and the least time-consuming method. Accordingly, the retention time of ZNS in the present study (2.8 min.) is the shortest run time compared to that reported by previous similar studies.

High reproducibility and ecofriendly are advantages of the proposed HPLC method over the proposed TLC- densitometry method. However, Procedure simplicity and rapid analysis were possessed using the proposed TLC- densitometry by spotting numerous samples on one plate and developing all together at the same time.

In the current HPLC method, solvents with hazardous effects on the environment were replaced with ethanol and water to avoid safety concerns, and adverse health effects. Recently, the global trend is directed to replace harmful solvents with safer ones [43]. Registration, Evaluation, Authorization, and Restriction of Chemicals regulation and the European Chemicals Agency encourage using green solvents to minimize the negative ecological and economic outcomes of hazardous solvents and their toxic wastes [44]. Regarding the effect of the methods on the environment, Eco-Scale, GAPI and AGREE tools indicate that these two suggested methods are considered more ecofriendly than pharmacopeia HPLC method [10].

Firstly, the Eco-Scale tool evaluates the greenness of the analytical method, with a score of 100 corresponding to the ideal method. Greenness assessment of method achieved via penalty points as excellent green analysis determined with score > 75 while acceptable with score > 50 and inadequate analysis with score < 50 [45]. The calculated scores for the proposed methods, (84) and (91) for the TLC-densitometry and the HPLC methods, respectively (Table 5).

Table 5 Penalty points of greenness assessment of the chromatographic suggested methods by Eco-Scale

Secondly, low hazardous impact of the developed methods via GAPI has been demonstrated. The results are illustrated by color scale pictogram consisting of five pentagrams which include; sample preparation, reagent and solvent, as well as instrumentation. Green color refers to much safer impact to the nature, yellow means problematic impact while the red color refers a hazardous impact to the nature and preferred to be avoided. Pictogram of the proposed HPLC method resulted in 9 green colors, 2 red and 4 yellow while the proposed TLC pictogram resulted in 10 green colors, 3 red and 2 yellow, which representing greener more than the official one as shown in (Table 6).

Table 6 Greenness assessment of the chromatographic proposed methods by GAPI and AGREE

Finally, the greenness assessment of the proposed chromatographic methods was conducted using AGREE tool. Twelve principles have been applied using greenness calculator software that achieves a clock like graph. AGREE pictogram demonstrating a score in the middle with color grading from intense green to intense red that illustrated the eco-friendly impact. AGREE pictograms of the developed HPLC and TLC-densitometry methods show a score of (0.75) and (0.76) with faint green colors, respectively. The results of the comparison between the obtained method and the official USP method [10] shown in (Table 6) prove that the suggested methods were more ecofriendly. Despite the greenness scores of ZNS official method and their proximity to the suggested ones; it was observed that the official method remains to have a negative impact consistent with Environment, Health and Safety [EHS] [46], as pharmacopeia HPLC method use acetonitrile in its mobile phase. In addition, using various buffers consumes time and chemicals during preparation steps. According to the list ranked by the American Chemical Society Green Chemistry Institute®, the mobile phase of the proposed HPLC method constitute two of the top three green solvents [43, 47].


Zonisamide was only sensitive to oxidation degradation. To date, the degradation pathway and structure of the degradation product haven’t been demonstrated by IR or mass spectrometry. The suggested chromatographic methods for the routine analysis of ZNS have been demonstrated to be valid and efficient. The greenness assessment of the suggested methods revealed their superiority over the official one. By studying and optimizing the impact of three distinct variables simultaneously, independently, and in combination, the experimental design achieved a crucial objective in optimizing the simple, rapid, and robust HPLC method.

Availability of data and materials

Datasets generated and/or analyzed during the current study are available from the corresponding author on reasonable request.


  1. Anastas PT, Warner JC. Green chemistry: theory and practice. Oxford: Oxford University Press; 1998. p. 29–56.

    Google Scholar 

  2. Ravichandran S. Environmental pollution control through green chemistry. Int J Chem Tech Res. 2018;11:293–7.

    Article  CAS  Google Scholar 

  3. Elsheikh SG, Hassan AM, Fayez YM, El-Mosallamy SS. Greenness assessment of two validated stability-indicating chromatographic methods for estimating modafinil using the analytical Eco-Scale. J AOAC Int. 2021;2:379–86.

    Article  Google Scholar 

  4. Sahu PK, Ramisetti NR, Cecchi T, Swain S, Patro CS, Panda J. An overview of experimental designs in HPLC method development and validation. J Pharm Biomed Anal. 2018;147:590–611.

    Article  CAS  PubMed  Google Scholar 

  5. Kurmi M, Kumar S, Singh B, Singh S. Implementation of design of experiments for optimization of forced degradation conditions and development of a stability-indicating method for furosemide. J Pharm Biomed Anal. 2014;96:135–43.

    Article  CAS  PubMed  Google Scholar 

  6. Veerubhotla K, Walker R. Development and validation of a stability-indicating RP-HPLC method using quality by design for estimating captopril. Indian J Pharm Sci. 2019;81:45–56.

    Article  CAS  Google Scholar 

  7. Kokilambigai K, Lakshmi K. Analytical quality by design assisted RP-HPLC method for quantifying atorvastatin with green analyical chemistry perspective. J Chromatogr A. 2022.

    Article  Google Scholar 

  8. Saroj S, Shah P, Jairaj V, Rathod R. Green analytical chemistry and quality by design: a combined approach towards robust and sustainable modern analysis. Curr Anal Chem. 2018;14:367–81.

    Article  CAS  Google Scholar 

  9. Prajapati PB, Bodiwala KB, Shah SA. Analytical quality-by-design approach for the stability study of thiocolchicoside by eco-friendly chromatographic method. JPC-J Planar Chromat. 2018;31:477–87.

    Article  CAS  Google Scholar 

  10. United States Pharmacopeia and National Formulary (USP 37–NF 32), United States Pharmacopeial convention, Rockville. 2014.

  11. Leppik IE. Zonisamide: chemistry, mechanism of action, and pharmacokinetics. Seizure. 2004;13:S5–9.

    Article  PubMed  Google Scholar 

  12. Mori A, Noda Y, Packer L. The anticonvulsant Zonisamide scavenges free radicals. Epilepsy Res. 1998;30:153–8.

    Article  CAS  PubMed  Google Scholar 

  13. Yoshida T, Imai K, Motohashi S, Hamano S-I, Sato M. Simultaneous determination of Zonisamide, carbamazepine and carbamazepine-10, 11-epoxide in infant serum by high-performance liquid chromatography. J Pharm Biomed Anal. 2006;41:1386–90.

    Article  CAS  PubMed  Google Scholar 

  14. Greiner-Sosanko E, Lower DR, Virji MA, Krasowski MD. Simultaneous determination of Lamotrigine, Zonisamide, and carbamazepine in human plasma by high-performance liquid chromatography. Biomed Chromatogr. 2007;21:225–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Majnooni M, Mohammadi B, Jalili R, Bahrami G. Rapid and sensitive high performance liquid chromatographic determination of Zonisamide in human serum application to a pharmacokinetic study. Indian J Pharm Sci. 2012;74:360–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Meyyanathan S, Bandla R, Babu B, Kalaivani M. HPLC method for the estimation of Zonisamide in its formulation. J Posit Psychol. 2022;6:1449–52.

    Google Scholar 

  17. Nimbokar S, Badukale N, Panchale W, Bakal R, Gudalwar B, Manwar J. Development and validation of RP-HPLC method for determination of zonisamide from tablet formulation. World J Pharm Res. 2021;7:196–200.

    Google Scholar 

  18. Rmandić M, Stajić A, Jančić J, Samardžić J, Jović N, Malenović A. Quantification of Zonisamide in dried blood spots and dried plasma spots by UPLC–MS/MS: application to clinical practice. Molecules. 2022;27(15):4899.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Paw B, Wos K. Development and validation of a capillary electrophoresis method for determination of Oxcarbazepine and Zonisamide in pharmaceuticals. J Pre-Clin Clin Res. 2008;2:157–9.

    Google Scholar 

  20. Kataoka Y, Makino K, Oishi R. Capillary electrophoresis for therapeutic drug monitoring of antiepileptics. J Electrophor. 1998;19:2856–60.

    Article  CAS  Google Scholar 

  21. Antonilli L, Brusadin V, Filipponi F, Guglielmi R, Nencini P. Development and validation of an analytical method based on high performance thin layer chromatography for the simultaneous determination of lamotrigine, zonisamide and levetiracetam in human plasma. J Pharm Biomed Anal. 2011;56:763–70.

    Article  CAS  PubMed  Google Scholar 

  22. Munshi RP, Gawde N. Development and validation of a HPTLC method to determine serum Zonisamide levels for therapeutic drug monitoring in clinical settings. Indian J Pharm Sci. 2019;81:385–9.

    Article  CAS  Google Scholar 

  23. Gholivand MB, Khodadadian M, Majnooni MB, Bahrami G. Electroreduction of Zonisamide at hanging mercury drop electrode and its determination in pharmaceutical formulations and spiked human serum samples. Anal Lett. 2010;43:269–79.

    Article  CAS  Google Scholar 

  24. Rao D, Chakravarthy I, Kumar S. Stability indicating HPLC method for the determination of Zonisamide as bulk drug and in pharmaceutical dosage form. Chromatographia. 2006;64:261–6.

    Article  CAS  Google Scholar 

  25. Wani RD, Gaikwad BP, Bairagi SH. Development and stability indicating studies of Zonisamide by RP-HPLC method in capsule dosage form. World J Pharm Sci. 2017;6:1480–7.

    Article  CAS  Google Scholar 

  26. Hosseini M, Alipour E, Farokhsir A. Determination and validation of zonisamide and its four related substances by HPLC and UV-spectrophotometry. Indian J Pharm Sci. 2010;72:302–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Raghuram P, Raju IS, Sriramulu J. A rapid stability indicating LC method for Zonisamide using RR-LC. Anal chem : Indian j. 2008;7:832–8.

    CAS  Google Scholar 

  28. Vijayakumar E, Dhore D, Kumar M. HPLC method for simultaneous determination of impurities and degradation products in Zonisamide. Indian J Pharm Sci. 2009;71:521–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Divan TA, Patel BA, Parmar SJ. Development and validation of simple UV spectroscopic method for estimation of Zonisamide in bulk and pharmaceutical Dosgae form. Int J Pharm Biol Sci. 2013;3:57–63.

    CAS  Google Scholar 

  30. Alothman ZA, Rahman N, Siddiqui MR. Review on pharmaceutical impurities, stability studies and degradation products: an analytical approach. Rev Adv Sci Eng. 2013;2:155–66.

    Article  Google Scholar 

  31. Kaur M, Kaur G, Kaur H, Sharma S. Overview on stability Studies. Int J Pharm Chem Biol Sci. 2013;3:1231–41.

    Google Scholar 

  32. Sharma M, Kothari C, Sherikar O, Mehta P. Concurrent estimation of amlodipine besylate, hydrochlorothiazide and valsartan by RP-HPLC, HPTLC and UV–spectrophotometry. J Chromatogr Sci. 2014;52:27–35.

    Article  CAS  PubMed  Google Scholar 

  33. Zaheer Z, Farooqui M, Nikalje AMA. Stability-indicating high performance liquid chromatographic determination of atorvastatin calcium in pharmaceutical dosage form. Afr J Pharm Pharmacol. 2008;2:204–10.

    Google Scholar 

  34. Kalariya PD, Namdev D, Srinivas R, Gananadhamu S. Application of experimental design and response surface technique for selecting the optimum RP-HPLC conditions for the determination of moxifloxacin HCl and ketorolac tromethamine in eye drops. J Saudi Chem Soc. 2017;21:S373–82.

    Article  CAS  Google Scholar 

  35. Kumar L, Reddy MS, Managuli RS, Pai G. Full factorial design for optimization, development and validation of HPLC method to determine valsartan in nanoparticles. Saudi Pharm J. 2015;23:549–55.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Prajapati PB, Radadiya K, Shah SA. Quality risk management based: analytical quality by design approach to eco-friendly and versatile chromatography method for simultaneous estimation of multiple fixed-dose-combination products of anti-diabetic drugs. J Pharm Innov. 2020;17:111–28.

    Article  Google Scholar 

  37. Prajapati P, Shah H, Shah SA. Implementation of QRM and DoE-based quality by design approach to VEER chromatography method for simultaneous estimation of multiple combined dosage forms of paracetamol. J Pharm Innov. 2020;17:2–18.

    Article  Google Scholar 

  38. Prajapati P, Patel A, Shah S. DoE-based analytical quality risk management for enhanced AQbD approach to economical and eco-friendly RP-HPLC method for synchronous estimation of multiple FDC products of antihypertensive drugs. J Chromatogr Sci. 2022;60:786–99.

    Article  CAS  PubMed  Google Scholar 

  39. Prajapati P, Shahi A, Acharya A, Shah S. Chemometric and design of experiments-based analytical quality by design and green chemistry approaches to multipurpose high-pressure liquid chromatographic method for synchronous estimation of multiple fixed-dose combinations of azilsartan medoxomil. J AOAC Int. 2022.

    Article  PubMed  Google Scholar 

  40. ICH. Q2 (R1): validation of analytical procedures: text and methodology. In: International Conference on Harmonization, Geneva, 2005.

  41. Reddy KA. Determination of zonisamide in capsule dosage form by using RP-HPLC. Int J Chem Sci. 2011;9:1698–704.

    CAS  Google Scholar 

  42. Rao BU, Nikalje AP. Determination of furosemide and Zonisamide as a drug substance and in dosage form by ion pair-reversed phase liquid chromatographic technique. J Appl Pharm Sci. 2012;2:94–9.

    Article  CAS  Google Scholar 

  43. American Chemical Society (Green Chemical Institute®). ACS GCI Pharmaceutical Roundtable Solvent Selection Guide. Accessed 21 Mar 2011.

  44. Bergkamp L, Herbatschek N. Regulating chemical substances under REACH: the choice between authorization and restriction and the case of dipolar aprotic solvents. Rev Eur Comp Int Environ Law. 2014;23:221–45.

    Article  Google Scholar 

  45. Gałuszka A, Migaszewski ZM, Konieczka P, Namieśnik J. Analytical Eco-Scale for assessing the greenness of analytical procedures. Trends Analyt Chem. 2012;37:61–72.

    Article  CAS  Google Scholar 

  46. Capello C, Fischer U, Hungerbühler K. What is a green solvent? A comprehensive framework for the environmental assessment of solvents. Green Chem. 2007;9:927–34.

    Article  CAS  Google Scholar 

  47. Dessouky Y, Hassanein H, Mohammad MA-A, Hanafy R. Normal phase high performance liquid chromatographic determination of chlorphenoxamine hydrochloride, caffeine and 8-chlorotheophylline. Bull Fac Pharm Cairo Univ. 2004;42:53–63.

    Google Scholar 

Download references


The authors express their gratitude to Mash premiere pharmaceuticals Company for donating us the pure Zonisamide sample.


Open access funding provided by The Science, Technology & Innovation Funding Authority (STDF) in cooperation with The Egyptian Knowledge Bank (EKB). This work wasn’t funded by any third party.

Author information

Authors and Affiliations



SGE investigation, software, validation, formal analysis, writing—original draft. AMEH conceptualization, investigation, supervision, review and editing, YMF conceptualization supervision, writing—review and editing, SSE conceptualization, methodology, investigation, writing—review and editing.

Corresponding author

Correspondence to Sally S. El-Mosallamy.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Elsheikh, S.G., Hassan, A.M.E., Fayez, Y.M. et al. Green analytical chemistry and experimental design: a combined approach for the analysis of zonisamide. BMC Chemistry 17, 38 (2023).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI:


  • Experimental design
  • Green Analytical chemistry
  • Stability indicating method
  • Zonisamide